Skip to main content
OpenTrials
Completed

NCT Number: NCT07746570

SU JOK THERAPY TO IMPROVE DYSPNEA AND INSOMNIA IN ASTHMA

Asthma is a long-term lung disease that can make breathing difficult and can also affect sleep. Even with regular medical treatment, many people with asthma continue to experience shortness of breath and insomnia. This study will examine whether Su Jok therapy, a complementary therapy that applies gentle stimulation to specific points on the hands and feet, can help reduce shortness of breath and improve sleep in people with asthma. Adults with asthma who agree to participate will be randomly assigned to one of two groups. One group will receive Su Jok therapy in addition to their usual care, while the other group will receive usual care only. Researchers will compare changes in breathing difficulty and sleep quality between the two groups.

The results of this study may help determine whether Su Jok therapy can be used as a safe and supportive treatment alongside standard asthma care.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Asthma Bronchial Diseases Dyspnea Dyssomnias Hypersensitivity Hypersensitivity, Immediate Immune System Diseases Insomnia Lung Diseases Lung Diseases, Obstructive Mental Disorders Nervous System Diseases Pathological Conditions, Signs and Symptoms Respiration Disorders Respiratory Hypersensitivity Respiratory Tract Diseases Signs and Symptoms Signs and Symptoms, Respiratory Sleep Disorders, Intrinsic Sleep Initiation and Maintenance Disorders Sleep Wake Disorders

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Erzincan Binali Yıldırım University

Erzincan, Merkez, 24100, Turkey (Türkiye)

About this study

Asthma is a chronic inflammatory disease of the airways that is characterized by recurrent episodes of dyspnea, wheezing, cough, and chest tightness. Despite advances in pharmacological treatment, many people with asthma continue to experience persistent symptoms, particularly dyspnea and sleep disturbances, which may negatively affect daily functioning and quality of life.

Complementary therapies are increasingly being investigated as supportive approaches to symptom management. Su Jok therapy is a complementary therapy based on the stimulation of specific points on the hands and feet that correspond to different parts of the body. It has been suggested that this approach may help relieve symptoms and improve overall well-being.

This randomized controlled trial aims to evaluate the effect of Su Jok therapy on dyspnea and insomnia in adults with asthma. Participants will be randomly assigned to either an intervention group receiving Su Jok therapy in addition to routine care or a control group receiving routine care alone. Dyspnea and insomnia will be assessed before and after the intervention using validated measurement instruments. The findings of this study are expected to provide evidence regarding the potential role of Su Jok therapy as a complementary, non-pharmacological intervention for symptom management in individuals with asthma.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults aged 18 years or older.
  • Diagnosed with asthma by a physician.
  • A baseline Visual Analog Scale (VAS) score of 3 or higher for both dyspnea and insomnia.
  • Receiving routine asthma treatment.
  • Able to communicate in Turkish.
  • Able to understand the study procedures and provide written informed consent.
  • Willing to participate in the study.

Exclusion criteria

  • Presence of severe cognitive or psychiatric disorders that could interfere with participation.
  • Presence of skin lesions, infection, or injury on the hands that would prevent Su Jok therapy.
  • Participation in another clinical trial during the study period.
  • Withdrawal of consent at any stage of the study.

Treatment and study plan

su jok therapy

Other

Su Jok therapy was administered by the researcher once daily for five consecutive days in addition to routine asthma care. The intervention involved stimulation of predefined Su Jok correspondence points on the hands according to the study protocol. Each session was performed using standardized procedures to ensure consistency throughout the study.

Primary outcomes

  1. Dyspnea severity

    Time frame: Baseline and daily for 5 consecutive days, with post-intervention assessment on Day 5.

    Dyspnea severity will be assessed using the Visual Analog Scale (VAS). Higher scores indicate greater dyspnea severity.

Secondary outcomes

  1. Insomnia severity

    Time frame: Baseline and post-intervention (Day 5).

    Insomnia severity will be assessed using the Visual Analog Scale (VAS) and the Insomnia Severity Index (ISI). Higher scores indicate greater insomnia severity.

Sponsors and collaborators

Lead sponsor

Erzincan Binali Yildirim Universitesi

Other

Registry information

Official study title

THE EFFECT OF SU JOK THERAPY ON DYSPNEA AND INSOMNIA IN PATIENTS WITH ASTHMA: A RANDOMIZED CONTROLLED TRIAL

Acronym: SUJOK-ASTHMA

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Aug 5, 2026
Registry last updated
Aug 6, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.